JY
IMA

Jeff Yass’s ImageneBio Inc IMA Stock Holding History

Jeff Yass’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,095
Closed -$17.6K – 13104
2025
Q2 		$17.6K Buy
+1,095
New +$16.1K ﹤0.01% 12353
2024
Q4 		– Sell
-4,758
Closed -$98.8K – 12664
2024
Q3 		$98.8K Sell
4,758
-2,177
-31% -$44K ﹤0.01% 11059
2024
Q2 		$137K Buy
+6,935
New +$122K ﹤0.01% 10786
2024
Q1 		– Sell
-1,681
Closed -$39.7K – 12702
2023
Q4 		$39.7K Buy
+1,681
New +$54.8K ﹤0.01% 11799
2023
Q2 		– Sell
-3,311
Closed -$137K – 12569
2023
Q1 		$137K Buy
+3,311
New +$152K ﹤0.01% 11001
2022
Q1 		– Sell
-1,214
Closed -$183K – 13455
2021
Q4 		$183K Buy
+1,214
New +$197K ﹤0.01% 11552

Other funds holding IMA

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Jeff Yass's IMA Position: Q3 2025 in Review

Jeff Yass sold out of ImageneBio Inc (IMA) in Q3 2025, closing a stake of 1,095 shares — an estimated $17.6K sold.

Jeff Yass first reported a position in IMA in Q4 2021 and held it in 6 quarters. The position peaked at $183K in Q4 2021. 33 funds tracked by Wall St. Rank hold IMA as of Q3 2025.

  • Jeff Yass reported no remaining ImageneBio Inc position as of Q3 2025 after selling out during the quarter.
  • Jeff Yass sold 1,095 ImageneBio Inc shares in Q3 2025, an estimated $17.6K.
  • Jeff Yass first reported a position in ImageneBio Inc in Q4 2021 and held it in 6 quarters.
  • Jeff Yass's ImageneBio Inc position peaked at $183K in Q4 2021.
  • 33 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.